NCT05330494

Brief Summary

Adenoidectomy and tonsillectomy are generally performed during childhood to help reduce snoring and improve sleep or caused by recurrent infection.And insufficient analgesia may result in postoperative sore throat, difficulty swallowing, aspiration, delayed discharge, spasm, and agitation. Remedial analgesic drugs such as morphine and opioids may lead to postoperative respiration depression, desaturation and vomiting.Transcutaneous electrical acupoint stimulation (TEAS) is a peripheral stimulation, which is a modern therapy derived from traditional acupuncture. Relevant clinical trials show that it can effectively relieve pain, and has slight side-effects.However, most of these clinical trials are conducted in adults, and there have been few clinical trials involving children. For this reason, in line with good tolerance and less side effects of TEAS, ,this study is designed to enhance the therapeutic effect of adenoidectomy and tonsillectomy pain by means of taking advantage of the skin-sticking electro-acupuncture.It is also hoped that this study can certify if TEAS can reduce the amount and side effects of analgesic drugs, such as morphine, and improve the postoperative safety of children, and moreover, explore the possible mechanisms by which TEAS relieve pain in children.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 16, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

April 15, 2022

Completed
10 days until next milestone

Study Start

First participant enrolled

April 25, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 10, 2023

Completed
Last Updated

May 3, 2022

Status Verified

May 1, 2022

Enrollment Period

6 months

First QC Date

January 16, 2022

Last Update Submit

May 2, 2022

Conditions

Keywords

Transcutaneous acupoint electrical stimulationadenoidectomytonsillectomypainagitation

Outcome Measures

Primary Outcomes (2)

  • change from pain score within 48 hours after surgery

    it is caused by procedure , and assessed with the Face, Legs, Activity, Cry, Consolability (FLACC )pain scale,a higher score indicates more severe pain

    interval 5minutes for the first 30 minutes after extubation, and then for the outstanding 24 hours and 48 hours after surgery

  • change from agitation score within 48 hours after surgery

    postoperative agitation is a reformed state of mindfulness, which starts with a sudden form of anesthesia and progresses through the early repossession age,it is assessed with the Pediatric Anesthesia Emergence Delirium (PAED) scale.It includes five objects (eye contact with the caregiver, purposeful action, and awareness of surroundings, restlessness, and inconsolability). Each item was scored by five scores (0 to 4) permitting to its degree, for a maximum of 20 points.Agitation was defined as a PAED 10 points.

    interval 5 minutes for the first 30 minutes after extubation, and then for the outstanding 24 hours and 48 hours after surgery

Secondary Outcomes (15)

  • duration of anesthesia

    Intraoperative (from the start of induction to endotracheal tube (EET) removal)

  • duration of surgery

    Intraoperative (from the insertion of the mouth gag to removal of the mouth gag)

  • recovery time

    Intraoperative (from sevoflurane discontinuation to spontaneous eye opening)

  • extubation time

    Intraoperative (from discontinuation of sevoflurane to tracheal extubation)

  • PACU length of stay(PACU-LOS)

    up to 48 hours (from the time patients' arrival in PACU to the time leaving PACU after surgery)

  • +10 more secondary outcomes

Study Arms (4)

S1

EXPERIMENTAL

TEAS treatment initiated at 30 minutes before induction and lasted for 30min,TEAS treatment(disperse-dense waves; frequency, 2/100 Hz)on acupoints Hegu(LI4) , Neiguan(PC6) and Zusanli(ST 36)of both sides, and the present intensity(8~12 mA) was the maximum current that could be tolerated.Then, the TEAS treatment was administered twice a day (once in the morning and once in the afternoon) on the first and second postoperative day, which lasted for 30 minutes each time.

Other: transcutaneous electrical acupoint stimulation(TEAS)

S2

EXPERIMENTAL

TEAS treatment initiated immediately after induction and stopped at the end of surgery,TEAS treatment(disperse-dense waves; frequency, 2/100 Hz)on acupoints Hegu(LI4) , Neiguan(PC6) and Zusanli(ST 36)of both sides, and the present intensity(8~12 mA) was the maximum current that could be tolerated.Then, the TEAS treatment was administered twice a day (once in the morning and once in the afternoon) on the first and second postoperative day, which lasted for 30 minutes each time.

Other: transcutaneous electrical acupoint stimulation(TEAS)

S3

EXPERIMENTAL

TEAS treatment initiated immediately after extubating and lasted for 30 minutes,TEAS treatment(disperse-dense waves; frequency, 2/100 Hz)on acupoints Hegu(LI4) , Neiguan(PC6) and Zusanli(ST 36)of both sides, and the present intensity(8~12 mA) was the maximum current that could be tolerated.Then, the TEAS treatment was administered twice a day (once in the morning and once in the afternoon) on the first and second postoperative day, which lasted for 30 minutes each time.

Other: transcutaneous electrical acupoint stimulation(TEAS)

control

SHAM COMPARATOR

the control group was given all manipulations without electrical stimulation, electrodes were placed on the same acupoints, but no current was given

Other: transcutaneous electrical acupoint stimulation(TEAS)

Interventions

transcutaneous electrical acupoint stimulation (TEAS), the modern therapies derived from traditional acupuncture, which could activate nerve endings or fibers and generate action potentials.s. TEAS uses self-adhesive electrodes placed on the surface of acupoints, instead of needles for electrical stimulation.The resulting stimulation signals, which are transmitted to the spinal cord and brain, stimulate the central nervous system to generate specific chemical mediators to induce relevant physiological effects.

S1S2S3control

Eligibility Criteria

Age4 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • the American Society of Anesthesiologists physical status Ⅰ and Ⅱ.
  • Ranging in age from 4 to 10.
  • Suffering from adenoid and/or tonsil hypertrophy
  • Preparing for elective surgery under general anesthesia with a signed written informed consent by parents..

You may not qualify if:

  • immunological, neurological, and hematological disorders
  • having any drug allergy or asthma, as well as allergic constitution
  • with congenital heart disease or various malignant arrhythmias
  • skin infections existing at acupoints and their surroundings
  • history of receiving acupuncture or electroacupuncture treatment
  • long-term use of analgesic or sedative drugs
  • used to having unilateral tonsil ablation
  • refusing to join the trial investigator
  • postoperative trachea spasm or laryngeal edema occurring

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xi'an Children's Hospital

Xi'an, Shaanxi, 710000, China

RECRUITING

MeSH Terms

Conditions

Psychomotor AgitationPain

Condition Hierarchy (Ancestors)

DyskinesiasNeurologic ManifestationsNervous System DiseasesPsychomotor DisordersNeurobehavioral ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsAberrant Motor Behavior in DementiaBehavioral SymptomsBehavior

Study Officials

  • Fang Li Yang

    Xi 'an children's hospital

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 16, 2022

First Posted

April 15, 2022

Study Start

April 25, 2022

Primary Completion

October 30, 2022

Study Completion

March 10, 2023

Last Updated

May 3, 2022

Record last verified: 2022-05

Locations